| Opening of Offer to Buy – Acquisition Window (Buyback) for J.B. Chemicals & Pharmaceuticals Limited |
Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All Market Participants are hereby informed that J.B. Chemicals & Pharmaceuticals Limited (“Company”) has announced cash Offer for buy-back of up to 33,33,333 (Thirty Three Lakhs Thirty Three Thousand Three Hundred And Thirty Three) fully paid-up equity shares of the Company of face value of Rs. 2/- (Rupees Two Only) each (“Equity Share(s)”) from all the shareholders holding Equity Shares / beneficial owners of equity shares of the Company, as on the Record Date i.e., Wednesday, September 12, 2018 (“Record Date”), on a proportionate basis, through the Tender Offer Route using
stock exchange mechanism (“Tender Offer”), at a price of Rs. 390/- (Rupees Three Hundred and Ninety Only) per Equity Share (“Buy-back Price”) for an aggregate amount not exceeding Rs. 130,00,00,000/- (Rupees One Hundred and Thirty Crores Only) (“Buy-back Size”) from October 10, 2018 to October 24, 2018.
Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Bhushan Mokashi
Additional General Manager
Listing Sales & Ops
October 04, 2018 |